Beam Therapeutics (BEAM)
Develops base-edited medicines for sickle cell disease and inherited metabolic disorders.
$26.00
After hours+0.08 (+0.31%)
At close$25.92(+2.61%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$1.16
Revenue estimate
$8.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.09−$1.24−$1.00−$1.10−$0.10−$0.91−$1.18Pending
Estimate−$1.25−$1.11−$1.04−$0.98−$1.13−$0.87−$1.11−$1.16
Surprise+12.8%−11.7%+3.8%−12.2%+91.2%−4.6%−6.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$30.1M$7.5M$8.5M$9.7M$114.1M$31.7M$490.0KPending
Estimate$16.5M$15.5M$11.5M$13.2M$11.7M$11.0M$16.4M$8.8M
Surprise+82.5%−51.9%−26.6%−26.6%+877.9%+189.1%−97.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.09 | — | — |
| Sep 2027 | −$1.26 | — | — |
| Jun 2027 | −$1.24 | — | — |
| Mar 2027 | −$1.11 | — | — |
| Dec 2026 | −$1.18 | — | — |
| Nov 2026 | −$1.16 | — | — |
| Aug 2026 | −$1.11 | −$1.18 | −6.3% |
| May 2026 | −$0.87 | −$0.91 | −4.6% |
| Feb 2026 | −$1.13 | −$0.10 | +91.2% |
| Nov 2025 | −$0.98 | −$1.10 | −12.2% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Feb 2020 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.09 | — | — | $27.7M | — | — | — |
| Sep 2027 | −$1.26 | — | — | $14.2M | — | — | — |
| Jun 2027 | −$1.24 | — | — | $14.2M | — | — | — |
| Mar 2027 | −$1.11 | — | — | $23.9M | — | — | — |
| Dec 2026 | −$1.18 | — | — | $10.1M | — | — | — |
| Nov 3, 2026 | −$1.16 | — | — | $8.8M | — | — | — |
| Aug 4, 2026 | −$1.11 | −$1.18 | −6.3% | $16.4M | $490.0K | −97.0% | +9.4% |
| May 7, 2026 | −$0.87 | −$0.91 | −4.6% | $11.0M | $31.7M | +189.1% | −2.7% |
| Feb 24, 2026 | −$1.13 | −$0.10 | +91.2% | $11.7M | $114.1M | +877.9% | +14.0% |
| Nov 4, 2025 | −$0.98 | −$1.10 | −12.2% | $13.2M | $9.7M | −26.6% | −6.2% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 10, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 15, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Feb 7, 2020 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |